In agreement with these results, deficiency of complement inhibitors such as CD59 promoted atherogenesis (123) . However, it is noteworthy that both downstream complement defects and activation of the terminal pathway were as-sociated with inherited proatherogenic effects and an increased risk of cardiovascular disease (124) .